A Phase 2 Clinical Study of CU-20401

NCT06194188 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

108

Enrollment

INDUSTRY

Sponsor class

Conditions

Efficacy and Safety

Interventions

DRUG: Subcutaneous injection of CU-20401

Sponsor

Cutia Therapeutics（Wuxi）Co.,Ltd